Injectable Product Availability

Please see the table below for information about in-line Teva injectable product availability. For more information about Teva’s injectable products, please contact your account manager.

To access information about current drug shortages, please visit:
www.ashp.org/menu/DrugShortages
www.fda.gov/Drugs/DrugSafety/DrugShortages

Product NDC Strength Size Status
Adenosine Injection, USP 00703-8776-01 3 mg/mL, 60 mg 20 mL/Vial On backorder; Estimated resupply TBD
Adenosine Injection, USP 00703-8777-01 3 mg/mL, 90 mg 30 mL/Vial Available
Alprostadil Injection, USP 00703-1501-02 500 mcg/mL, 500 mcg 1 mL/Vial x 5 On backorder; Estimated resupply TBD
Amikacin Sulfate Injection, USP 00703-9040-03 250 mg/mL, 1 gm 4 mL/Vial x 10 On backorder; Estimated resupply TBD. 
Amikacin Sulfate Injection, USP 00703-9032-03 250 mg/mL, 500 mg 2 mL/Vial x 10 On backorder; Estimated resupply TBD. 
Bleomycin for Injection, USP 00703-3154-01 15 units/Vial 15 units/Vial Available
Bleomycin for Injection, USP 00703-3155-01 30 units/Vial 30 units/Vial Available
Carboplatin Injection 00703-4244-01 10 mg/mL, 50 mg 5 mL/Vial Available
Carboplatin Injection 00703-4246-01 10 mg/mL, 150 mg 15 mL/Vial On backorder; Estimated resupply September 2022
Carboplatin Injection 00703-4248-01 10 mg/mL, 450 mg 45 mL/Vial Available
Carboplatin Injection 00703-4239-01 10 mg/mL, 600 mg 60 mL/Vial Available
Cisatracurium Besylate Injection, USP 00703-2033-03 2 mg/mL, 10 mg 5 mL Vials x 10 Available
Cisatracurium Besylate Injection, USP 00703-2056-03 2 mg/mL, 20 mg 10 mL Vials x 10 Available
Cisatracurium Besylate Injection, USP 00703-2045-03 10 mg/mL, 200 mg 20 mL Vials x 10 Available
Cisplatin Injection 00703-5747-11 1 mg/mL, 50 mg 50 mL/Vial Available
Cisplatin Injection 00703-5748-11 1 mg/mL, 100 mg 100 mL/Vial Available
Dacarbazine for Injection, USP 00703-5075-01 200 mg/Vial 20 mL/Vial On backorder; Estimated resupply TBD
Dacarbazine for Injection, USP 00703-5075-03 200 mg/Vial 20 mL/Vial x 10 On backorder; Estimated resupply TBD
Daunorubicin Hydrochloride Injection 00703-5233-13 5 mg/mL, 20 mg 4 mL/Vial x 10 On backorder; Estimated resupply TBD
Desmopressin Acetate Injection, USP 00703-5051-03 4 mcg/mL 1 mL/Vial x 10 On backorder; Estimated resupply TBD
Desmopressin Acetate Injection, USP 00703-5054-01 4 mcg/mL 10 mL/Vial On backorder; Estimated resupply TBD
Docetaxel Injection Concentrate 45963-0734-54 20 mg/mL 1 mL/Vial Available
Docetaxel Injection Concentrate 45963-0765-52 20 mg/mL, 80 mg 4 mL/Vial Available
Doxorubicin Hydrochloride Injection, USP 45963-0733-55 2 mg/mL, 10 mg 5 mL/Vial Available
Doxorubicin Hydrochloride Injection, USP 45963-0733-57 2 mg/mL, 20 mg 10 mL/Vial On backorder; Estimated resupply Oct 2022
Doxorubicin Hydrochloride Injection, USP 45963-0733-68 2 mg/mL, 50 mg 25 mL/Vial Temporarily Unavailable effective 10/25/2021. Estimated resupply Oct 2022
Doxorubicin Hydrochloride Injection, USP 45963-0733-60 2 mg/mL, 200 mg 100 mL/Vial On backorder; Estimated resupply Sept 2022
Epoprostenol Sodium for Injection 00703-1985-01 0.5 mg/Vial 10 mL/Vial On backorder; Estimated resupply TBD
Epoprostenol Sodium for Injection 00703-1995-01 1.5 mg/Vial 10 mL/Vial On backorder; Estimated resupply TBD
Epoprostenol Sodium for Injection 00703-9258-09 (Diluent) 50 mL/Vial x 2 Available
Fludarabine Phosphate for Injection, USP 45963-0621-51 25 mg/mL, 50 mg 2 mL/Vial Temporarily Unavailable effective 11/22/2021
Fludarabine Phosphate for Injection, USP 45963-0609-55 50 mg/Vial 1 Vial On allocation. Please check frequently with your wholesaler.
Fosaprepitant for Injection 00591-4385-79 150 mg/Vial 1 Single-Dose Vial Available
Fulvestrant Injection 00591-5019-02 250 mg/5 mL (50 mg/mL) 2 Single-Dose Prefilled Syringes Available
Haloperidol Decanoate Injection 00703-7121-03 50 mg/mL, 50 mg 1 mL/Vial x 10 On backorder; Estimated resupply TBD
Haloperidol Decanoate Injection 00703-7123-01 50 mg/mL, 250 mg 5 mL/Vial On backorder; Estimated resupply TBD
Haloperidol Decanoate Injection 00703-7131-03 100 mg/mL, 100 mg 1 mL/Vial x 10 On Backorder; Estimated resupply TBD
Haloperidol Decanoate Injection 00703-7133-01 100 mg/mL, 500 mg 5 mL/Vial On backorder; Estimated resupply TBD. Short Dated Product Available Exp June 30, 2022
Hydromorphone Hydrochloride Injection, USP CII 00703-0110-03 10 mg/mL, 10 mg 1 mL/Vial x 10 Available
Hydromorphone Hydrochloride Injection, USP CII 00703-0113-03 10 mg/mL, 50 mg 5 mL/Vial x 10 On Backorder; Estimated resupply May 2022
Hydromorphone Hydrochloride Injection, USP CII 00703-0018-01 10 mg/mL, 500 mg 50 mL/Vial Available
Icatibant Injection 00093-3066-34 30 mg/3 mL 1 carton containing one Single-Dose Prefilled Syringe Available
Icatibant Injection 00093-3066-93 30 mg/3 mL 3 cartons, each containing one Single-Dose Prefilled Syringe Available
Idarubicin Hydrochloride Injection 00703-4154-11 1 mg/mL, 5 mg 5 mL/Vial On backorder; Estimated resupply TBD
Idarubicin Hydrochloride Injection 00703-4155-11 1 mg/mL, 10 mg 10 mL/Vial Available
Idarubicin Hydrochloride Injection 00703-4156-11 1 mg/mL, 20 mg 20 mL/Vial On backorder; Estimated resupply TBD
Ifosfamide Injection 00703-3427-11 50 mg/mL, 1 gm 20 mL/Vial On backorder; Estimated resupply TBD
Ifosfamide Injection 00703-3429-11 50 mg/mL, 3 gm 60 mL/Vial On backorder; Estimated resupply TBD
Irinotecan Hydrochloride Injection, USP 45963-0614-51 20 mg/mL, 40 mg 2 mL/Vial Available
Irinotecan Hydrochloride Injection, USP 45963-0614-55 20 mg/mL, 100 mg 5 mL/Vial Available
Leucovorin Calcium for Injection 00703-5140-01 100 mg/Vial 1 Vial On backorder; Estimated resupply TBD
Leucovorin Calcium for Injection 00703-5145-01 350 mg/Vial 1 Vial On backorder; Estimated resupply TBD
Medroxyprogesterone Acetate Injectable Suspension, USP 00703-6801-01 150 mg/mL, 150 mg 1 mL/Vial On backorder; Estimated resupply TBD
Medroxyprogesterone Acetate Injectable Suspension, USP 00703-6801-04 150 mg/mL, 150 mg 1 mL/Vial x 25 On backorder; Estimated resupply TBD
Melphalan Hydrochloride for Injection 45963-0686-02 50 mg/Vial 2 Vials/Carton: Melphalan Hydrochloride for Injection and 10 mL Diluent Available
Methotrexate Injection, USP 00703-3678-01 25 mg/mL, 1 gm 40 mL/Vial Available
Methotrexate Injection, USP 00703-3671-01 25 mg/mL, 50 mg 2 mL/Vial Available
Methotrexate Injection, USP 00703-3675-01 25 mg/mL, 250 mg 10 mL/Vial Available
Methylprednisolone Acetate Injectable Suspension, USP 00703-0031-01 40 mg/mL, 40 mg 1 mL/Vial On backorder; Estimated resupply TBD
Methylprednisolone Acetate Injectable Suspension, USP 00703-0031-04 40 mg/mL, 40 mg 1 mL/Vial x 25 On backorder; Estimated resupply TBD
Methylprednisolone Acetate Injectable Suspension, USP 00703-0043-01 40 mg/mL, 200 mg 5 mL/Vial On backorder; Estimated resupply TBD
Methylprednisolone Acetate Injectable Suspension, USP 00703-0045-01 40 mg/mL, 400 mg 10 mL/Vial On backorder; Estimated resupply TBD
Methylprednisolone Acetate Injectable Suspension, USP 00703-0051-01 80 mg/mL, 80 mg 1 mL/Vial On backorder; Estimated resupply TBD
Methylprednisolone Acetate Injectable Suspension, USP 00703-0051-04 80 mg/mL, 80 mg 1 mL/Vial x 25 On backorder; Estimated resupply TBD
Methylprednisolone Acetate Injectable Suspension, USP 00703-0063-01 80 mg/mL, 400 mg 5 mL/Vial On backorder; Estimated resupply TBD
Metoclopramide Injection, USP 00703-4502-04 5 mg/mL, 10 mg 2 mL/Vial x 25 Available
Mitoxantrone Injection, USP (Concentrate) 00703-4685-01 2 mg/mL, 20 mg 10 mL/Vial On backorder; Estimated resupply TBD
Mitoxantrone Injection, USP (Concentrate) 00703-4680-01 2 mg/mL, 25 mg 12.5 mL/Vial On Backorder; Estimated resupply TBD
Mitoxantrone Injection, USP (Concentrate) 00703-4686-01 2 mg/mL, 30 mg 15 mL/Vial On backorder; Estimated resupply TBD
Norepinephrine Bitartrate Injection, USP 00703-1153-03 1 mg/mL, 4 mg 4 mL Vial x 10 On Backorder. Estimated resupply TBD.
Octreotide Acetate Injection 00703-3301-04 50 mcg/mL, 50 mcg 1 mL/Vial x 25 On backorder; Estimated resupply TBD
Octreotide Acetate Injection 00703-3311-04 100 mcg/mL, 100 mcg 1 mL/Vial x 25 On backorder; Estimated resupply TBD
Octreotide Acetate Injection 00703-3333-01 200 mcg/mL, 1000 mcg 5 mL/Vial Available
Octreotide Acetate Injection 00703-3321-04 500 mcg/mL, 500 mcg 1 mL/Vial x 25 On backorder; Estimated resupply TBD
Octreotide Acetate Injection 00703-3343-01 1000 mcg/mL, 5000 mcg 5 mL/Vial On backorder; Estimated resupply TBD
Oxaliplatin for Injection, USP 45963-0611-53 50 mg/Vial 1 Vial Available
Oxaliplatin for Injection, USP 45963-0611-59 100 mg/Vial 1 Vial Available
Oxaliplatin Injection 00703-3985-01 5 mg/mL, 50 mg 10 mL/Vial Available
Oxaliplatin Injection 00703-3986-01 5 mg/mL, 100 mg 20 mL/Vial Available
Paclitaxel Injection, USP 00703-3213-01 6 mg/mL, 30 mg 5 mL/Vial Available
Paclitaxel Injection, USP 00703-3216-01 6 mg/mL, 100 mg 16.7 mL/Vial Available
Paclitaxel Injection, USP 00703-3217-01 6 mg/mL, 150 mg 25 mL/Vial Available
Paclitaxel Injection, USP 00703-3218-01 6 mg/mL, 300 mg 50 mL/Vial Available
Palonosetron Hydrochloride Injection 00703-4094-01 0.05 mg/mL, 0.25 mg 5 mL/Vial Available
Pemetrexed Injection 00480-4516-01 100 mg/4 mL Single-Dose Vial Available
Pemetrexed Injection 00480-4514-01 500 mg/20 mL Single-Dose Vial Available
Pemetrexed Injection 00480-4515-01 1 g/40 mL Single-Dose Vial Available
Propofol Injection Emulsion, USP 00591-2136-95 10 mg/mL, 200 mg 20 mL/Vial x 25 Available
Propofol Injection Emulsion, USP 00591-2136-51 10 mg/mL, 500 mg 50 mL/Vial x 20 On backorder; Estimated resupply TBD
Propofol Injection Emulsion, USP 00591-2136-68 10 mg/mL, 1000 mg 100 mL/Vial x 10 On backorder; Estimated resupply May 2022
Scopolamine Transdermal System 00591-2258-04 1 mg/3 days 4 Systems/Carton New Product Available - Effective 05/12/2022
Scopolamine Transdermal System 00591-2258-79 1 mg/3 days 10 Systems/Carton New Product Available - Effective 05/12/2022
Scopolamine Transdermal System 00591-2258-23 1 mg/3 days 24 Systems/Carton New Product Available - Effective 05/12/2022
Sulfamethoxazole and Trimethoprim Injection, USP 00703-9503-03 80 mg/16 mg/mL 5 mL/Vial x 10 On backorder; Estimated resupply Sept 2022
Sulfamethoxazole and Trimethoprim Injection, USP 00703-9514-03 80 mg/16 mg/mL 10 mL/Vial x 10 Available
Sulfamethoxazole and Trimethoprim Injection, USP 00703-9526-01 80 mg/16 mg/mL 30 mL/Vial On backorder; Estimated resupply September 2022
Toposar® (Etoposide Injection, USP) 00703-5657-01 20 mg/mL, 1 gm 50 mL/Vial On backorder; Estimated resupply TBD
Toposar® (Etoposide Injection, USP) 00703-5653-01 20 mg/mL, 100 mg 5 mL/Vial On backorder; Estimated resupply TBD
Toposar® (Etoposide Injection, USP) 00703-5656-01 20 mg/mL, 500 mg 25 mL/Vial On backorder; Estimated resupply TBD
Topotecan Hydrochloride for Injection 45963-0615-56 4 mg 1 Vial Available
Topotecan Injection 00703-4714-01 1 mg/mL, 4 mg 4 mL/Vial Available
Treprostinil Injection 00703-0666-01 1 mg/mL (20 mg) 1 Carton, 20 mL Vial Available
Treprostinil Injection 00703-0676-01 2.5 mg/mL (50 mg) 1 Carton, 20 mL Vial Available
Treprostinil Injection 00703-0686-01 5 mg/mL (100 mg) 1 Carton, 20 mL Vial Available
Treprostinil Injection 00703-0696-01 10 mg/mL (200 mg) 1 Carton, 20 mL Vial Available
Triamcinolone Acetonide Injectable Suspension, USP 00703-0241-01 40 mg/mL (40 mg) 1 mL Single-Dose Vial Available
Triamcinolone Acetonide Injectable Suspension, USP 00703-0243-01 40 mg/mL (200 mg) 5 mL Multiple-Dose Vial Available
Triamcinolone Acetonide Injectable Suspension, USP 00703-0245-01 40 mg/mL (400 mg) 10 mL Multiple-Dose Vial Available
Vecuronium Bromide for Injection 00703-2914-03 10 mg/Vial 10 mL/Vial x 10 On backorder; Estimated resupply TBD
Vincasar PFS® (vincristine sulfate injection USP) 00703-4402-11 1 mg/mL, 1 mg 1 mL/Vial Available
Vincasar PFS® (vincristine sulfate injection USP) 00703-4412-11 1 mg/mL, 2 mg 2 mL/Vial On backorder; Estimated resupply TBD
Vinorelbine Injection, USP 45963-0607-55 10 mg/mL, 10 mg 1 mL/Vial Available
Vinorelbine Injection, USP 45963-0607-56 10 mg/mL, 50 mg 5 mL/Vial Available
ZANOSAR® (Streptozocin Sterile Powder) 00703-4636-01 1 gm/Vial 1 Vial On backorder; Estimated resupply TBD. Short Dated Product Available Exp June 30, 2022

As of 2 September 2022